- Home
- VERB vs TOVX Comparison
VERB vs TOVX Comparison
Compare VERB & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- TOVX
- Stock Information
- Founded
- VERB 2014
- TOVX 2001
- Country
- VERB United States
- TOVX United States
- Employees
- VERB N/A
- TOVX N/A
- Industry
- VERB Other Consumer Services
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- TOVX Health Care
- Exchange
- VERB Nasdaq
- TOVX Nasdaq
- Market Cap
- VERB 4.7M
- TOVX 4.7M
- IPO Year
- VERB N/A
- TOVX 2006
- Fundamental
- Price
- VERB $4.31
- TOVX $1.18
- Analyst Decision
- VERB Strong Buy
- TOVX Strong Buy
- Analyst Count
- VERB 1
- TOVX 1
- Target Price
- VERB $100.00
- TOVX $6.00
- AVG Volume (30 Days)
- VERB 33.5K
- TOVX 23.5K
- Earning Date
- VERB 05-09-2025
- TOVX 05-06-2025
- Dividend Yield
- VERB N/A
- TOVX N/A
- EPS Growth
- VERB N/A
- TOVX N/A
- EPS
- VERB N/A
- TOVX N/A
- Revenue
- VERB $895,000.00
- TOVX N/A
- Revenue This Year
- VERB $36.76
- TOVX N/A
- Revenue Next Year
- VERB N/A
- TOVX N/A
- P/E Ratio
- VERB N/A
- TOVX N/A
- Revenue Growth
- VERB 1320.63
- TOVX N/A
- 52 Week Low
- VERB $4.29
- TOVX $1.03
- 52 Week High
- VERB $53.60
- TOVX $12.25
- Technical
- Relative Strength Index (RSI)
- VERB 36.22
- TOVX 44.04
- Support Level
- VERB $4.51
- TOVX $1.08
- Resistance Level
- VERB $4.99
- TOVX $1.21
- Average True Range (ATR)
- VERB 0.54
- TOVX 0.07
- MACD
- VERB -0.07
- TOVX 0.00
- Stochastic Oscillator
- VERB 0.95
- TOVX 57.89
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.